Back |
home / stock / syrs / syrs message board
Subject | By | Source | When |
---|---|---|---|
$SYRS is a great $$$$$ opportunity. | crudeoil24 | investorshub | 12/20/2019 2:24:55 PM |
Even more good news this am....... | hedge_fun | investorshub | 12/20/2019 1:28:47 PM |
I bought in when they announced the partnership | trustbutverifyit | investorshub | 12/20/2019 12:39:01 AM |
* * $SYRS Video Chart 12-18-2019 * * | ClayTrader | investorshub | 12/18/2019 10:17:27 PM |
Wow, we beat estimates. Now lets reverse course......... | hedge_fun | investorshub | 11/12/2019 1:49:49 PM |
87,5 % institutional ownership: https://fintel.io/so/us/syrs | Greenspam3 | investorshub | 08/18/2019 9:42:52 AM |
Nice momentum run, expecting big pop to $27+. $SYRS | Chief-money | investorshub | 08/18/2019 8:25:02 AM |
* * $SYRS Video Chart 06-29-2019 * * | ClayTrader | investorshub | 06/29/2019 7:21:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Syros Pharmaceuticals Inc. Company Name:
SYRS Stock Symbol:
NASDAQ Market:
Syros Pharmaceuticals Inc. Website:
2024-06-18 10:10:00 ET June 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring A...
-- Three medical experts will join members of Syros’ leadership team to provide an overview of HR-MDS patient management, perspectives on the current and future treatment landscape, and the opportunity for tamibarotene on Tuesday, June 25 at 11:00 a.m. ET -- -- Syros expects to rep...
2024-05-27 04:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...